Cardioxane (active substance dexrazoxane) a drug used in adults with breast cancer to prevent long-term harmful effects on the heart caused by anthracycline (doxorubicin and epirubicin).
Now Cardioxane is authorised in the Czech Republic, Germany, France, Italy, the Netherlands, Poland, Spain and the United Kingdom.
If you have experience to use dexrazoxane in real clinical practice?
How often is the drug used?